Top

Published in:

Open Access 01-12-2018 | Research article

Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa

Authors: Oladele Vincent Adeniyi, Anthony Idowu Ajayi, Daniel Ter Goon, Eyitayo Omolara Owolabi, Alfred Eboh, John Lambert

Published in: BMC Infectious Diseases | Issue 1/2018

Abstract

Background

Context-specific factors influence adherence to antiretroviral therapy (ART) among pregnant women living with HIV. Gaps exist in the understanding of the reasons for the variable outcomes of the prevention of mother-to-child transmission (PMTCT) programme at the health facility level in South Africa. This study examined adherence levels and reasons for non-adherence during pregnancy in a cohort of parturient women enrolled in the PMTCT programme in the Eastern Cape, South Africa.

Methods

This was a mixed-methods study involving 1709 parturient women in the Eastern Cape, South Africa. We conducted a multi-centre retrospective analysis of the mother-infant pair in the PMTCT electronic database in 2016. Semi-structured interviews of purposively selected parturient women with self-reported poor adherence (n = 177) were conducted to gain understanding of the main barriers to adherence. Binary logistic regression was used to determine the independent predictors of ART non-adherence.

Results

A high proportion (69.0%) of women reported perfect adherence. In the logistic regression analysis, after adjusting for confounding factors, marital status, cigarette smoking, alcohol use and non-disclosure to a family member were the independent predictors of non-adherence. Analysis of the qualitative data revealed that drug-related side-effects, being away from home, forgetfulness, non-disclosure, stigma and work-related demand were among the main reasons for non-adherence to ART.

Conclusions

Non-adherence to the antiretroviral therapy among pregnant women in this setting is associated with lifestyle behaviours, HIV-related stigma and ART side-effects. In order to eliminate mother-to-child transmission of HIV, clinicians need to screen for these factors at every antenatal clinic visit.

Broder S. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antivir Res. 2010;85(1):1–18.CrossRefPubMed

Bor J, Herbst AJ, Newell M-L, et al. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339(6122):961–5.CrossRefPubMed

Antiretroviral Therapy Cohort Collaboration. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol. 2009;38(6):1624.CrossRef

Ndirangu J, Newell M-L, Tanser F, et al. Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact? AIDS (London, England). 2010;24(4):593.CrossRef

Bhardwaj S, Treger-Slavin L, Barron P, et al. Elimination of mother-to-child transmission of HIV in South Africa: rapid scale-up using quality improvement: prevention of mother-to-child transmission-progress towards the millennium development goals. S Afr Med J. 2014;104(3):239–43.CrossRefPubMed

Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002;7(3):185–93.PubMed

Chesney M. Adherence to HAART regimens. AIDS Patient Care STDs. 2003;17(4):169–77.CrossRefPubMed

Tanser F, Bärnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71.CrossRefPubMedPubMedCentral

Maggiolo F, Di Filippo E, Comi L, et al. Reduced adherence to antiretroviral therapy is associated with residual low-level viremia. Pragmat Obs Res. 2017;8:91.CrossRefPubMedPubMedCentral

10.

Hoffmann CJ, Cohn S, Mashabela F, et al. Treatment failure, drug resistance, and CD4 T-cell count decline among postpartum women on antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr. 2016;71(1):31.PubMedPubMedCentral

11.

Mekuria LA, Prins JM, Yalew AW, et al. Which adherence measure–self-report, clinician recorded or pharmacy refill–is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring? Tropical Med Int Health. 2016;21(7):856–69.CrossRef

12.

Gueorguieva R, Wu R, Krystal JH, et al. Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response. Addict Behav. 2013;38(5):2119–27.CrossRefPubMedPubMedCentral

13.

Vaz MJR, Barros SMO, Palacios R, et al. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. Int J STD AIDS. 2007;18(1):28–32.CrossRefPubMed

14.

Ramlagan S, Alcaide M, Rodriguez V, Peltzer K, Weiss S, Jones D. Low Adherence to ARV among HIV-Infected Pregnant Women in rural South Africa. Open Forum Infect Dis. 2016;3(suppl_1):1499.

15.

Colombini M, Stöckl H, Watts C, et al. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination. AIDS Care. 2014;26(7):914–26.CrossRefPubMed

16.

Mukui IN, Williamson J, Wamicwe JN, et al. Rates and predictors of non-adherence to antiretroviral therapy among HIV-positive individuals in Kenya: results from the second Kenya AIDS Indicator survey, 2012. PLoS One. 2016;11(12):e0167465.CrossRefPubMedPubMedCentral

17.

Haas AD, Msukwa MT, Egger M, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi’s option B+ program. Clin Infect Dis. 2016;63(9):1227–35.PubMedPubMedCentral

18.

Bardeguez AD, Lindsey JC, Shannon M, et al. Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune defic Syndr. 2008;48(4):408.CrossRefPubMedPubMedCentral

19.

Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183.CrossRefPubMedPubMedCentral

20.

Azia IN, Mukumbang FC, Van Wyk B. Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, western cape, South Africa. Southern Afr J HIV Med. 2016;17(1):1–8.

21.

Ankrah DN, Koster ES, Mantel-Teeuwisse AK, et al. Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Prefer Adherence. 2016;10:329.CrossRefPubMedPubMedCentral

22.

Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.CrossRefPubMedPubMedCentral

23.

Loeliger KB, Niccolai LM, Mtungwa LN, et al. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers’ perspectives on barriers and facilitators. AIDS Care. 2016;28(8):982–93.CrossRefPubMedPubMedCentral

24.

Dima AL, Schweitzer A-M, Diaconiţǎ R, et al. Adherence to ARV medication in Romanian young adults: self-reported behaviour and psychological barriers. Psychol health Med. 2013;18(3):343–54.CrossRefPubMed

25.

Najjar A, Amro Y, Kitaneh I, et al. Knowledge and adherence to medications among Palestinian geriatrics living with chronic diseases in the West Bank and East Jerusalem. PLoS One. 2015;10(6):e0129240.CrossRefPubMedPubMedCentral

26.

Gugsa S, Potter K, Tweya H, et al. Exploring factors associated with ART adherence and retention in care under option B+ strategy in Malawi: a qualitative study. PLoS One. 2017;12(6):e0179838.CrossRefPubMedPubMedCentral

27.

Adeniyi O, Ajayi A, Selanto-Chairman N, et al. Demographic, clinical and behavioural determinants of HIV serostatus non-disclosure to sex partners among HIV-infected pregnant women in the eastern cape, South Africa. PLoS One. 2017;12(8):e0181730.CrossRefPubMedPubMedCentral

28.

Africa SS. Buffalo City metropolitan municipality, 2011.

29.

El-Khatib Z, Katzenstein D, Marrone G, et al. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One. 2011;6(3):e17518.CrossRefPubMedPubMedCentral

30.

Polkinghorne M, Arnold A. A six step guide to using recursive abstraction applied to the qualitative analysis of interview data. 2014.

31.

Alcaide ML, Ramlagan S, Rodriguez VJ, et al. Self-report and dry blood spot measurement of antiretroviral medications as markers of adherence in pregnant women in rural South Africa. AIDS Behav. 2017;21:2135.CrossRefPubMed

32.

Okonji JA, Zeh C, Weidle PJ, et al. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya. J Acquir Immune Defic Syndr. 2012;61(2):249–57.CrossRefPubMed

33.

Uzochukwu B, Onwujekwe O, Onoka A, et al. Determinants of non-adherence to subsidized anti-retroviral treatment in Southeast Nigeria. Health Policy Plan. 2009;24(3):189–96.CrossRefPubMed

34.

Pellowski JA, Kalichman SC. Health behavior predictors of medication adherence among low health literacy people living with HIV/AIDS. J Health Psychol. 2016;21(9):1981–91.CrossRefPubMed

35.

Kader R, Govender R, Seedat S, et al. Understanding the impact of hazardous and harmful use of alcohol and/or other drugs on ARV adherence and disease progression. PLoS One. 2015;10(5):e0125088.CrossRefPubMedPubMedCentral

36.

Hansana V, Sanchaisuriya P, Durham J, et al. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13(1):617.CrossRefPubMedPubMedCentral

37.

Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-, middle and high income countries: a systematic review and meta-analysis. AIDS (London, England). 2012;26(16):2039.CrossRefPubMedCentral

38.

Weiser SD, Tuller DM, Frongillo EA, et al. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5(4):e10340.CrossRefPubMedPubMedCentral

39.

Fonsah JY, Njamnshi AK, Kouanfack C, et al. Adherence to antiretroviral therapy (ART) in Yaoundé-Cameroon: association with opportunistic infections, depression, ART regimen and side effects. PLoS One. 2017;12(1):e0170893.CrossRefPubMedPubMedCentral

40.

Duran S, Spire B, Raffi F, et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV clinical trials. 2001;2(1):38–45.CrossRefPubMed

41.

Kim MH, Zhou A, Mazenga A, et al. Why did I stop? Barriers and facilitators to uptake and adherence to ART in option B+ HIV care in Lilongwe, Malawi. PLoS One. 2016;11(2):e0149527.CrossRefPubMedPubMedCentral

42.

Maixenchs M, Boene H, Anselmo R, et al. Post-ART symptoms were not the problem: a qualitative study on adherence to ART in HIV-infected patients in a Mozambican rural hospital. PLoS One. 2015;10(9):e0137336.CrossRefPubMedPubMedCentral

43.

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.CrossRefPubMed

Title: Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa
Authors: Oladele Vincent Adeniyi
Anthony Idowu Ajayi
Daniel Ter Goon
Eyitayo Omolara Owolabi
Alfred Eboh
John Lambert
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-018-3087-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Characterization of non-tuberculous mycobacterium from humans and water in an Agropastoral area in Zambia

Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report

Determinants of CD4 cell count change and time-to default from HAART; a comparison of separate and joint models

Intimate relationship characteristics as determinants of HIV risk among men who have sex with regular male sex partners: a cross-sectional study in Guangzhou, China

Spatial, temporal, and spatiotemporal analysis of mumps in Guangxi Province, China, 2005–2016

Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page